FCA
GSK icon

FinTrust Capital Advisors’s GSK GSK Stock Holding History

FinTrust Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$239K Buy
5,844
+1,341
+30% +$54.9K 0.04% 281
2024
Q2 		$173K Buy
4,503
+18
+0.4% +$757 0.03% 307
2024
Q1 		$192K Sell
4,485
-912
-17% -$37.6K 0.04% 290
2023
Q4 		$200K Buy
5,397
+1,051
+24% +$37.7K 0.04% 273
2023
Q3 		$158K Buy
4,346
+281
+7% +$9.97K 0.04% 287
2023
Q2 		$143K Hold
4,065
– – 0.03% 303
2023
Q1 		$143K Hold
4,065
– – 0.03% 301
2022
Q4 		$143K Buy
4,065
+1,647
+68% +$54.9K 0.03% 301
2022
Q3 		$76K Sell
2,418
-504
-17% -$19.1K 0.02% 431
2022
Q2 		$154K Sell
2,922
-985
-25% -$54.4K 0.04% 306
2022
Q1 		$213K Sell
3,907
-130
-3% -$7.06K 0.05% 277
2021
Q4 		$223K Buy
4,037
+943
+30% +$49.1K 0.05% 270
2021
Q3 		$148K Sell
3,094
-187
-6% -$9.39K 0.04% 325
2021
Q2 		$163K Buy
3,281
+471
+17% +$22.6K 0.04% 317
2021
Q1 		$125K Sell
2,810
-118
-4% -$5.36K 0.04% 359
2020
Q4 		$135K Sell
2,928
-216
-7% -$9.92K 0.04% 323
2020
Q3 		$148 Sell
3,144
-629
-17% -$31.5K 0.03% 289
2020
Q2 		$192K Sell
3,773
-634
-14% -$32.5K 0.08% 209
2020
Q1 		$209K Buy
4,407
+390
+10% +$20.8K 0.1% 174
2019
Q4 		$236K Sell
4,017
-302
-7% -$16.8K 0.1% 184
2019
Q3 		$230K Sell
4,319
-106
-2% -$5.45K 0.08% 192
2019
Q2 		$221K Sell
4,425
-674
-13% -$33.8K 0.09% 178
2019
Q1 		$266K Sell
5,099
-2,068
-29% -$103K 0.11% 158
2018
Q4 		$343K Buy
+7,167
New +$353K 0.17% 115

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FinTrust Capital Advisors's GSK Position: Q3 2024 in Review

FinTrust Capital Advisors increased its GSK (GSK) stake by 30% in Q3 2024, buying an estimated $54.9K and bringing the position to 5,844 shares worth $239K. The position accounts for 0.04% of the portfolio, ranked #281.

FinTrust Capital Advisors first reported a position in GSK in Q4 2018 and has held it in 24 quarters since. The position peaked at $343K in Q4 2018. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • FinTrust Capital Advisors held 5,844 shares of GSK worth $239K as of Q3 2024.
  • FinTrust Capital Advisors bought 1,341 GSK shares in Q3 2024, an estimated $54.9K.
  • GSK made up 0.04% of FinTrust Capital Advisors's portfolio in Q3 2024, its #281 holding.
  • FinTrust Capital Advisors first reported a position in GSK in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's GSK position peaked at $343K in Q4 2018.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.